PrediGen: A Tool for Tracing the Genealogy of Medical Devices
Overview
In the United States, medical devices are regulated and subject to review by the Food and Drug Administration (“FDA”) before they can be marketed. Novel medical devices have to undergo a premarket authorization (PMA) process before they can proceed to market, and this process can be fairly cumbersome, expensive, and time-consuming. An alternate faster and economic pathway to going to market is the 510(k) pathway. In this approach, if the medical device manufacturer can show that their device is substantially equivalent in safety and effectiveness to a pre-existing FDA-approved marketed device (or “predicates”), they can go to market with their device. However, medical devices cleared through the less rigorous 510(k) pathway comprise more than two-thirds of the products that are recalled by the FDA because they could seriously harm patients or result in death. Since 510(k) approved devices are approved through this predicate approach, it can very quickly be difficult to unravel the logic and justification of how a particular medical device’s equivalence was established. From a patient’s perspective, this minimizes transparency in the process. There is a pressing need for tracing predicate genealogy and its temporal evolution, in order to benefit consumers. Analysis of recalls as predicate lines evolve is crucial to ensuring consumer safety; understanding the recalls landscape can help protect device manufacturers when they are taking their medical devices through the regulatory approval process for marketing in the US. The goal of this project is to provide a more comprehensive view of the evolution of the U.S. FDA 510 (k) predicate system, focusing on approvals in recent years.
Competition history
- ISEF 2020
Resources
Related projects
ISEF · 2022
Medical Device Recall Prediction Using MAUDE Reports
ISEF · 2026
Scalable Hybrid Framework for Mapping the GPCR-Peptide Interactome: A Proactive Genome-Scale Safety Audit of GLP-1
ISEF · 2017
PrediMed: Predicting Health with a Custom-Built Machine Learning Ensemble
ISEF · 2014
A Novel Approach to Genetic Interaction Research with an Integrated Repository of Gene Regulatory Networks
ISEF · 2023
BioRx: An Integrative NLP Approach to Early Survival and Recurrence Prediction and Novel Biomarker Discovery in Unstructured Text-Based Clinical Narratives for Diabetes Patients
JSHS · 2020
Enabling Personalized Medicine: A Novel Deep Learning Tool for Classifying Genetic Mutations Using Text from Clinical Evidence
JSHS · 2020
The Pancreas Detective: A Novel Artificial-Intelligence-Based Post-Biopsy Tool to Screen Genetic Mutations Towards Personalizing Pancreatic Cancer Treatment
ISEF · 2020
Determining Gene Interactions in Congenital Heart Disease for Development of a Comprehensive Fetal Cardiac Diagnostics Platform
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair